Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
BMJ
    March 2024
  1. WONDERLING D, Mariani A, Samarasekera EJ, Wilkinson C, et al
    Secondary prevention of cardiovascular disease, including cholesterol targets: summary of updated NICE guidance.
    BMJ. 2024;384:q637.
    >> Share

  2. SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al
    Even short periods of diabetes remission are linked to lower risk of heart attack and stroke.
    BMJ. 2024;384:q516.
    >> Share

  3. TANNE JH
    Wegovy: FDA approves weight loss drug to cut cardiovascular risk.
    BMJ. 2024;384:q642.
    >> Share

    February 2024

  4. Exposure-response associations between chronic exposure to fine particulate matter and risks of hospital admission for major cardiovascular diseases: population based cohort study.
    BMJ. 2024;384:q517.
    >> Share

  5. WEI Y, Feng Y, Danesh Yazdi M, Yin K, et al
    Exposure-response associations between chronic exposure to fine particulate matter and risks of hospital admission for major cardiovascular diseases: population based cohort study.
    BMJ. 2024;384:e076939.
    >> Share

  6. SUN Y, Milando CW, Spangler KR, Wei Y, et al
    Short term exposure to low level ambient fine particulate matter and natural cause, cardiovascular, and respiratory morbidity among US adults with health insurance: case time series study.
    BMJ. 2024;384:e076322.
    >> Share

  7. KIM KS, Hong S, Han K, Park CY, et al
    Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study.
    BMJ. 2024;384:e076388.
    >> Share

  8. MAHASE E
    Variability in blood pressure could help predict heart attack and stroke risk, researchers say.
    BMJ. 2024;384:q363.
    >> Share

    January 2024
  9. WISE J
    Early deaths from cardiovascular disease reach 14 year high in England.
    BMJ. 2024;384:q176.
    >> Share

  10. PHIZACKERLEY D
    Semaglutide reduces the absolute risk of major cardiovascular events by 1.5.
    BMJ. 2024;384:q53.
    >> Share

    December 2023
  11. KMIETOWICZ Z
    NICE lowers cholesterol target for people with cardiovascular disease.
    BMJ. 2023;383:p2946.
    >> Share

    November 2023
  12. GEBRE AK, Sim M, Schultz C
    Do high sensitivity cardiac troponin assays improve patient outcomes?
    BMJ. 2023;383:2741.
    >> Share

  13. LEE KK, Doudesis D, Ferry AV, Chapman AR, et al
    Implementation of a high sensitivity cardiac troponin I assay and risk of myocardial infarction or death at five years: observational analysis of a stepped wedge, cluster randomised controlled trial.
    BMJ. 2023;383:e075009.
    >> Share

  14. KHAN SU, Agarwal S, Arshad HB, Akbar UA, et al
    Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis.
    BMJ. 2023;383:e077848.
    >> Share

  15. WISE J
    Semaglutide reduces risk of major cardiovascular events by 20%, finds study.
    BMJ. 2023;383:p2668.
    >> Share

    October 2023
  16. LEE YJ, Hong SJ, Kang WC, Hong BK, et al
    Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
    BMJ. 2023;383:e075837.
    >> Share

    September 2023
  17. HUANG WC, Yang AS, Tsai DH, Shao SC, et al
    Association between recently raised anticholinergic burden and risk of acute cardiovascular events: nationwide case-case-time-control study.
    BMJ. 2023;382:e076045.
    >> Share

  18. TSAI TY, Loh CH, Huang HK
    Anticholinergic medicines linked to cardiovascular events in older adults.
    BMJ. 2023;382:p2133.
    >> Share

  19. SELLEM L, Srour B, Javaux G, Chazelas E, et al
    Food additive emulsifiers and risk of cardiovascular disease in the NutriNet-Sante cohort: prospective cohort study.
    BMJ. 2023;382:e076058.
    >> Share

    August 2023
  20. RAU STEUERNAGEL C, Lam CSP, Greenhalgh T
    Countering sex and gender bias in cardiovascular research requires more than equal recruitment and sex disaggregated analyses.
    BMJ. 2023;382:e075031.
    >> Share

  21. STURMBERG J
    Study results show vitamin D is around 99% ineffective in preventing major cardiovascular events.
    BMJ. 2023;382:p1767.
    >> Share

  22. SATTAR N
    There is no evidence that vitamin D prevents cardiovascular events.
    BMJ. 2023;382:p1765.
    >> Share

    July 2023
  23. RALEIGH V, Colombo F
    Cardiovascular disease should be a priority for health systems globally.
    BMJ. 2023;382:e076576.
    >> Share

  24. BEERSTECHER HJ
    NICE guidance on cardiovascular disease risk assessment and reduction is disappointing.
    BMJ. 2023;382:p1506.
    >> Share

  25. SUMMERS DJ
    Cardiovascular disease: what does QRISK actually measure?
    BMJ. 2023;382:1502.
    >> Share

    June 2023
  26. THOMPSON B, Waterhouse M, English DR, McLeod DS, et al
    Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial.
    BMJ. 2023;381:e075230.
    >> Share

  27. GALE CP, Stocken DD, Aktaa S, Reynolds C, et al
    Effectiveness of GRACE risk score in patients admitted to hospital with non-ST elevation acute coronary syndrome (UKGRIS): parallel group cluster randomised controlled trial.
    BMJ. 2023;381:e073843.
    >> Share

    May 2023
  28. SAMARASEKERA EJ, Clark CE, Kaur S, Patel RS, et al
    Cardiovascular disease risk assessment and reduction: summary of updated NICE guidance.
    BMJ. 2023;381:1028.
    >> Share

    March 2023
  29. KARAM G, Agarwal A, Sadeghirad B, Jalink M, et al
    Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis.
    BMJ. 2023;380:e072003.
    >> Share

  30. MORALES DR, Minchin M, Kontopantelis E, Roland M, et al
    Estimated impact from the withdrawal of primary care financial incentives on selected indicators of quality of care in Scotland: controlled interrupted time series analysis.
    BMJ. 2023;380:e072098.
    >> Share

  31. LITTLE MP, Azizova TV, Richardson DB, Tapio S, et al
    Ionising radiation and cardiovascular disease: systematic review and meta-analysis.
    BMJ. 2023;380:e072924.
    >> Share

  32. AUVINEN A
    Increased cardiovascular disease risk after exposure to low dose radiation.
    BMJ. 2023;380:e074589.
    >> Share

    February 2023
  33. CRUMP C, Sundquist J, McLaughlin MA, Dolan SM, et al
    Adverse pregnancy outcomes and long term risk of ischemic heart disease in mothers: national cohort and co-sibling study.
    BMJ. 2023;380:e072112.
    >> Share

    January 2023
  34. O'DOWD A
    NICE recommends wider use of statins to cut cardiovascular risk.
    BMJ. 2023;380:p89.
    >> Share

    October 2022

  35. Comparative effectiveness of initial computed tomography and invasive coronary angiography in women and men with stable chest pain and suspected coronary artery disease: multicentre randomised trial.
    BMJ. 2022;379:e071133.
    >> Share

    September 2022
  36. XIE W, Wang Y, Xiao S, Qiu L, et al
    Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis.
    BMJ. 2022;378:e070244.
    >> Share

  37. YUN I
    Regional inequality in myocardial infarction treatment cannot be blamed on effectiveness of individual cardiologists.
    BMJ. 2022;378:o2235.
    >> Share

  38. DEBRAS C, Chazelas E, Sellem L, Porcher R, et al
    Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Sante cohort.
    BMJ. 2022;378:e071204.
    >> Share

    June 2022
  39. WISE J
    NICE endorses new drug to prevent myocardial infarctions and strokes.
    BMJ. 2022;377:o1444.
    >> Share

  40. AL-LAMEE RK, Foley M, Rajkumar CA, Francis DP, et al
    Revascularization in stable coronary artery disease.
    BMJ. 2022;377:e067085.
    >> Share

    May 2022
  41. LU Y, Melnick ER, Krumholz HM
    Clinical decision support in cardiovascular medicine.
    BMJ. 2022;377:e059818.
    >> Share


  42. Variation in revascularisation use and outcomes of patients in hospital with acute myocardial infarction across six high income countries: cross sectional cohort study.
    BMJ. 2022;377:o1161.
    >> Share

  43. CRAM P, Hatfield LA, Bakx P, Banerjee A, et al
    Variation in revascularisation use and outcomes of patients in hospital with acute myocardial infarction across six high income countries: cross sectional cohort study.
    BMJ. 2022;377:e069164.
    >> Share

  44. KHAN SU, Yedlapati SH, Lone AN, Hao Q, et al
    PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis.
    BMJ. 2022;377:e069116.
    >> Share

  45. HAO Q, Aertgeerts B, Guyatt G, Bekkering GE, et al
    PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.
    BMJ. 2022;377:e069066.
    >> Share

    April 2022
  46. HARSKAMP RE, Fanaroff AC, Zhen SW, Sawe HR, et al
    Recognising acute coronary syndrome.
    BMJ. 2022;377:e069591.
    >> Share

    March 2022
  47. HODKINSON A, Tsimpida D, Kontopantelis E, Rutter MK, et al
    Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis.
    BMJ. 2022;376:e067731.
    >> Share

  48. MAHASE E
    Study questions relationship between statins and cardiovascular outcomes.
    BMJ. 2022;376:o712.
    >> Share

    February 2022

  49. Early computed tomography coronary angiography in patients with suspected acute coronary syndrome: randomised controlled trial.
    BMJ. 2022;376:o438.
    >> Share

  50. TANNE JH
    Six in 10 US women have poor cardiovascular health before pregnancy, study finds.
    BMJ. 2022;376:o402.
    >> Share

    January 2022

  51. P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.
    BMJ. 2022;376:o239.
    >> Share

  52. BRUSH JE JR, Sherbino J, Norman GR
    Diagnostic reasoning in cardiovascular medicine.
    BMJ. 2022;376:e064389.
    >> Share

    November 2021
  53. FU EL, Evans M, Carrero JJ, Putter H, et al
    Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study.
    BMJ. 2021;375:e066306.
    >> Share

  54. BELTRAME JF, Tavella R, Jones D, Zeitz C, et al
    Management of ischaemia with non-obstructive coronary arteries (INOCA).
    BMJ. 2021;375:e060602.
    >> Share

  55. SAUL H, Gursul D
    Even low doses of steroids increase the risk of cardiovascular disease in people with inflammatory diseases.
    BMJ. 2021;375:n2599.
    >> Share

    October 2021
  56. MAHASE E
    US taskforce advises against low dose aspirin for primary prevention of cardiovascular disease.
    BMJ. 2021;375:n2521.
    >> Share

  57. NAGHSHI S, Aune D, Beyene J, Mobarak S, et al
    Dietary intake and biomarkers of alpha linolenic acid and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of cohort studies.
    BMJ. 2021;375:n2213.
    >> Share

    September 2021
  58. GRAY AJ, Roobottom C, Smith JE, Goodacre S, et al
    Early computed tomography coronary angiography in patients with suspected acute coronary syndrome: randomised controlled trial.
    BMJ. 2021;374:n2106.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016